LMAT
Price
$94.44
Change
+$8.84 (+10.33%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
1.48B
84 days until earnings call
SYK
Price
$376.35
Change
+$1.41 (+0.38%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
134.94B
84 days until earnings call
Interact to see
Advertisement

LMAT vs SYK

Header iconLMAT vs SYK Comparison
Open Charts LMAT vs SYKBanner chart's image
LeMaitre Vascular
Price$94.44
Change+$8.84 (+10.33%)
Volume$2.2K
Capitalization1.48B
Stryker
Price$376.35
Change+$1.41 (+0.38%)
Volume$2.63K
Capitalization134.94B
LMAT vs SYK Comparison Chart in %
Loading...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LMAT vs. SYK commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a Hold and SYK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (LMAT: $94.44 vs. SYK: $374.94)
Brand notoriety: LMAT and SYK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LMAT: 216% vs. SYK: 119%
Market capitalization -- LMAT: $1.48B vs. SYK: $134.94B
LMAT [@Medical Specialties] is valued at $1.48B. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LMAT’s FA Score shows that 2 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • LMAT’s FA Score: 2 green, 3 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than LMAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LMAT’s TA Score shows that 6 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).

  • LMAT’s TA Score: 6 bullish, 4 bearish.
  • SYK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LMAT is a better buy in the short-term than SYK.

Price Growth

LMAT (@Medical Specialties) experienced а +16.25% price change this week, while SYK (@Medical Specialties) price change was -6.36% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.63%. For the same industry, the average monthly price growth was -1.59%, and the average quarterly price growth was -3.41%.

Reported Earning Dates

LMAT is expected to report earnings on Oct 30, 2025.

SYK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical Specialties (+0.63% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than LMAT($1.48B). LMAT has higher P/E ratio than SYK: LMAT (49.19) vs SYK (42.99). SYK YTD gains are higher at: 4.599 vs. LMAT (2.996). SYK has higher annual earnings (EBITDA): 4.93B vs. LMAT (49M). SYK has more cash in the bank: 3.05B vs. LMAT (105M). LMAT has less debt than SYK: LMAT (19.1M) vs SYK (13B). SYK has higher revenues than LMAT: SYK (20.5B) vs LMAT (193M).
LMATSYKLMAT / SYK
Capitalization1.48B135B1%
EBITDA49M4.93B1%
Gain YTD2.9964.59965%
P/E Ratio49.1942.99114%
Revenue193M20.5B1%
Total Cash105M3.05B3%
Total Debt19.1M13B0%
FUNDAMENTALS RATINGS
LMAT vs SYK: Fundamental Ratings
LMAT
SYK
OUTLOOK RATING
1..100
8362
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
1614
SMR RATING
1..100
5756
PRICE GROWTH RATING
1..100
5656
P/E GROWTH RATING
1..100
6221
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (21) in the Medical Specialties industry is in the same range as LMAT (28). This means that SYK’s stock grew similarly to LMAT’s over the last 12 months.

SYK's Profit vs Risk Rating (14) in the Medical Specialties industry is in the same range as LMAT (16). This means that SYK’s stock grew similarly to LMAT’s over the last 12 months.

SYK's SMR Rating (56) in the Medical Specialties industry is in the same range as LMAT (57). This means that SYK’s stock grew similarly to LMAT’s over the last 12 months.

SYK's Price Growth Rating (56) in the Medical Specialties industry is in the same range as LMAT (56). This means that SYK’s stock grew similarly to LMAT’s over the last 12 months.

SYK's P/E Growth Rating (21) in the Medical Specialties industry is somewhat better than the same rating for LMAT (62). This means that SYK’s stock grew somewhat faster than LMAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LMATSYK
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 4 days ago
33%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 16 days ago
57%
Declines
ODDS (%)
Bearish Trend 7 days ago
54%
Bearish Trend 2 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEIIX41.25N/A
N/A
Principal Equity Income Inst
PCGRX24.14N/A
N/A
Victory Pioneer Mid Cap Value A
MRAEX13.40N/A
N/A
Meridian Hedged Equity A
JMVIX16.27-0.02
-0.12%
Janus Henderson Mid Cap Value S
BWLYX24.53-0.08
-0.33%
American Beacon Man Lg Cp Value Y

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-1.55%
BSX - SYK
67%
Closely correlated
-1.79%
ISRG - SYK
64%
Loosely correlated
-0.62%
STE - SYK
58%
Loosely correlated
-1.19%
MDT - SYK
56%
Loosely correlated
-0.35%
A - SYK
56%
Loosely correlated
-1.44%
More